You are here:Home-Chemical Inhibitors & Agonists-Epigenetics-HDAC-CM-444
CM-444

Chemical Structure : CM-444

CAS No.: 2256079-52-2

CM-444 (CM444)

Catalog No.: PC-21608Not For Human Use, Lab Use Only.

CM-444 is a potent histone deacetylase (HDAC) inhibitor with IC50 of 7/51/18/531 nM for HDAC1/2/3/6 respectively, also inhibits DNMT1 with IC50 of 2160 nM.

Packing Price Stock Quantity
50 mg Get quote
100 mg Get quote
200 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

CM-444 is a potent histone deacetylase (HDAC) inhibitor with IC50 of 7/51/18/531 nM for HDAC1/2/3/6 respectively, also inhibits DNMT1 with IC50 of 2160 nM.
CM-444 does not inhibit G9a (IC50>10 uM).
CM-444 exhibits a potent antiproliferative response against the MM1.S cell line (GI50 = 32 nM).
CM-444 also shows potent antiproliferative activity against other MM cell lines (JJN3, KMS28BM, and H929) with GI50 values between 100 and 550 nM.
CM-444 (10 mg/kg, i.p.) shows in vivo efficacy in an MM1.S tumor model.

Physicochemical Properties

M.Wt 518.57
Formula C27H30N6O5
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

2-[4-[[[6,7-Dimethoxy-2-(5-methyl-2-furyl)-4-quinolyl]amino]methyl]-1-piperidyl]pyrimidine-5-carbohydroxamic Acid

References

1. Rabal O, et al. J Med Chem. 2021;64:3392–426.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: